Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Coleonol
2. Colforsin
3. N,n-dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1h-naphtho(2,1-b)pyran-6-yl Ester Hcl
4. Nkh 477
5. Nkh-477
6. Nkh477
1. Colforsin
2. 66575-29-9
3. Coleonol
4. Colforsina
5. Colforsine
6. Colforsinum
7. Boforsin
8. Hl 362
9. Coleonolk
10. L 75 1362b
11. Forskolin (gmp)
12. 7beta-acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one
13. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1h-benzo[f]chromen-5-yl Acetate
14. Hl-362
15. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1h-benzo[f]chromen-5-yl Acetate
16. Chembl52606
17. L-751362b
18. 1f7a44v6ou
19. [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] Acetate
20. Chebi:42471
21. Nsc375489
22. Nsc-357088
23. Nsc-375489
24. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1h-naphtho(2,1-b)pyran-1-one 5-acetate
25. Ncgc00024996-02
26. L-75-1362b
27. 66428-89-5
28. Dsstox_cid_20484
29. Dsstox_rid_79500
30. Dsstox_gsid_40484
31. 1h-naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3r,4ar,5s,6s,6as,10s,10ar,10bs)-
32. Colforsine [french]
33. Colforsinum [latin]
34. Colforsina [spanish]
35. Forslean
36. Colforsin [usan:inn]
37. Fok
38. Smr000471881
39. Cas-66575-29-9
40. C22h34o7
41. Einecs 266-410-9
42. Nsc 357088
43. Nsc 375489
44. Unii-1f7a44v6ou
45. Ocufors
46. Timsaponin-c
47. Forskolin- Bio-x
48. (-)-forskolin
49. Mfcd00082317
50. Forskolin - 10%
51. Forskolin - 20%
52. Forskolin - 40%
53. Colforsin [inn]
54. Colforsin [mi]
55. Colforsin (usan/inn)
56. Colforsin [usan]
57. Forskolin [vandf]
58. Colforsin [mart.]
59. Forskolin/ Rolipram Mixture
60. Molmap_000021
61. 7-beta-acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one
62. Colforsin [who-dd]
63. Forskolin [usp-rs]
64. Schembl4928
65. 1h-naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-
66. Cid_47936
67. Mls001066384
68. Mls001333255
69. Mls001333256
70. Mls002172462
71. Mls002695942
72. Forskolin, Analytical Standard
73. Forskohlii Root Extract (forslean)(20% Forskohlin)
74. Regid_for_cid_47936
75. Gtpl5190
76. Dtxsid8040484
77. Bcbcmap01_000132
78. Ohcqjhsobutrhg-kgghgjdlsa-
79. Bio1_000443
80. Bio1_000932
81. Bio1_001421
82. Hms2235c17
83. Hms3267i16
84. Hms3412g19
85. Hms3676g19
86. Ex-a5963
87. Zinc3977779
88. Tox21_110940
89. Tox21_302399
90. Bdbm50010261
91. Hy-15371g
92. S2449
93. Akos024456384
94. Tox21_110940_1
95. Am81249
96. Ccg-268774
97. Cs-1454
98. Db02587
99. Lmpr0104030004
100. Smp1_000128
101. Ncgc00024996-03
102. Ncgc00024996-04
103. Ncgc00024996-05
104. Ncgc00024996-06
105. Ncgc00024996-07
106. Ncgc00024996-34
107. Ncgc00177971-03
108. Ncgc00255526-01
109. 1h-naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3r-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha))-
110. 1h-naphtho(2,1-b)pyran-1-one, Dodecahydro-5-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-6,10,10b-trihydroxy-, (3r-(3-alpha,4a-beta,5-beta,6-beta,6a-alpha,10-alpha,10a-beta,10b-alpha))-
111. 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho(2,1-b)pyran-1-one
112. Ac-33150
113. As-17443
114. Bf164487
115. Hy-15371
116. Xf165210
117. Xf165211
118. Xf165212
119. Cs-0622781
120. F0855
121. M-410
122. C09076
123. D03584
124. Mls-0318096.0001
125. A850885
126. Q412747
127. Sr-01000597378
128. Forskolin (constituent Of Forskohlii) [dsc]
129. Forskolin, For Use In Molecular Biology Applications
130. Q-200888
131. Sr-01000597378-1
132. Brd-k09602097-001-04-5
133. Forskolin, From Coleus Forskohlii, >=98% (hplc), Powder
134. Forskolin, United States Pharmacopeia (usp) Reference Standard
135. Coleonol;7beta-acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one
136. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1h-naphtho[2,1-b]pyran-5-yl Acetate
137. [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyl-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] Acetate
138. [3r-(3 139. [3r-(3?,4a?,5?,6?,6a?,10?,10a?,10b?)]-5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho[2,1-b]pyran-1-one 140. [3r-(3a,4ab,5b,6b,6aa,10a,10ab,10ba)]-5-(acetyloxy)-3-e Thenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho[2,1-b]pyran-1-one
| Molecular Weight | 410.5 g/mol |
|---|---|
| Molecular Formula | C22H34O7 |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 410.23045342 g/mol |
| Monoisotopic Mass | 410.23045342 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 747 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Coleus Forskohlii Extract manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Coleus Forskohlii Extract, including repackagers and relabelers. The FDA regulates Coleus Forskohlii Extract manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Coleus Forskohlii Extract API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Coleus Forskohlii Extract manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Coleus Forskohlii Extract supplier is an individual or a company that provides Coleus Forskohlii Extract active pharmaceutical ingredient (API) or Coleus Forskohlii Extract finished formulations upon request. The Coleus Forskohlii Extract suppliers may include Coleus Forskohlii Extract API manufacturers, exporters, distributors and traders.
click here to find a list of Coleus Forskohlii Extract suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Coleus Forskohlii Extract DMF (Drug Master File) is a document detailing the whole manufacturing process of Coleus Forskohlii Extract active pharmaceutical ingredient (API) in detail. Different forms of Coleus Forskohlii Extract DMFs exist exist since differing nations have different regulations, such as Coleus Forskohlii Extract USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Coleus Forskohlii Extract DMF submitted to regulatory agencies in the US is known as a USDMF. Coleus Forskohlii Extract USDMF includes data on Coleus Forskohlii Extract's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Coleus Forskohlii Extract USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Coleus Forskohlii Extract suppliers with USDMF on PharmaCompass.
Coleus Forskohlii Extract Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Coleus Forskohlii Extract GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Coleus Forskohlii Extract GMP manufacturer or Coleus Forskohlii Extract GMP API supplier for your needs.
A Coleus Forskohlii Extract CoA (Certificate of Analysis) is a formal document that attests to Coleus Forskohlii Extract's compliance with Coleus Forskohlii Extract specifications and serves as a tool for batch-level quality control.
Coleus Forskohlii Extract CoA mostly includes findings from lab analyses of a specific batch. For each Coleus Forskohlii Extract CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Coleus Forskohlii Extract may be tested according to a variety of international standards, such as European Pharmacopoeia (Coleus Forskohlii Extract EP), Coleus Forskohlii Extract JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Coleus Forskohlii Extract USP).
LOOKING FOR A SUPPLIER?
